Cargando…
Metabolic Comorbidities in Vitiligo: A Brief Review and Report of New Data from a Single-Center Experience
Among disorders of pigmentation, vitiligo is the most common, with an estimated prevalence between 0.5% and 1%. The disease has gathered increased attention in the most recent years, leading to a better understanding of the disease’s pathophysiology and its implications and to the development of new...
Autores principales: | D’Arino, Andrea, Picardo, Mauro, Truglio, Mauro, Pacifico, Alessia, Iacovelli, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396221/ https://www.ncbi.nlm.nih.gov/pubmed/34445526 http://dx.doi.org/10.3390/ijms22168820 |
Ejemplares similares
-
A Possible Modulator of Vitiligo Metabolic Impairment: Rethinking a PPARγ Agonist
por: Papaccio, Federica, et al.
Publicado: (2022) -
A protective role for autophagy in vitiligo
por: Bastonini, Emanuela, et al.
Publicado: (2021) -
Regenerative Medicine-Based Treatment for Vitiligo: An Overview
por: Bellei, Barbara, et al.
Publicado: (2022) -
Vitiligo: A Possible Model of Degenerative Diseases
por: Bellei, Barbara, et al.
Publicado: (2013) -
Prevalence of Vitiligo and Associated Comorbidities in Korea
por: Lee, Hemin, et al.
Publicado: (2015)